New study seeks to improve treatment of Peripheral Artery Disease (PAD)
The South Australian Health and Medical Research Institute (SAHMRI), in partnership with CMAX, are running a world-leading study to improve the treatment of a common circulatory condition, Peripheral Artery Disease (PAD) and its associated leg pain.
SAHMRI's Heart Health Theme Leader and Deputy Director, Professor Steve Nicholls, spoke about PAD, and the importance of this study, with Professor of Vascular Surgery at the Basil Hetzel Institute, Professor Rob Fitridge.
WHO WE’RE LOOKING FOR
SAHMRI and CMAX are seeking 18 patients to participate in this study, who can meet the following main selection criteria:
- Male or female participants aged ≥ 40 years
- Diagnosis of PAD secondary to atherosclerosis
- Claudication symptoms of stable severity for at least 3 months
- Able to undertake treadmill exercise
- Do not have poorly controlled diabetes mellitus
- No history of CHF or presence of CHF as defined by modified Framingham criteria class II-IV
- Do not have uncontrolled hypertension, defined as ≥ 180 systolic or ≥ 90 diastolic mmHg
- Free from unstable angina within 3 months of screening
- Have not suffered from a TIA or stroke within 3 months prior to screening
